申请人:Genzyme Corporation
公开号:EP3424956A1
公开(公告)日:2019-01-09
Provided are binding polypeptides (e.g., antibodies), and effector moiety conjugates thereof, comprising a CH1 domain (e.g., a human IgG1 CH1 domain), wherein the CH1 domain has an engineered N-linked glycosylation site at amino acid position 114, according to Kabat numbering. Also provided are nucleic acids encoding the antigen-binding polypeptides, recombinant expression vectors and host cells for making such antigen-binding polypeptides. Methods of using the antigen-binding polypeptides disclosed herein to treat disease are also provided.
提供了包含 CH1 结构域(例如人 IgG1 CH1 结构域)的结合多肽(例如抗体)及其效应分子共轭物,其中根据 Kabat 编号,CH1 结构域在氨基酸位置 114 有一个工程化的 N-连接糖基化位点。此外,还提供了编码抗原结合多肽的核酸、重组表达载体和用于制造这种抗原结合多肽的宿主细胞。还提供了使用本文公开的抗原结合多肽治疗疾病的方法。